Rakhee Ganti

Company: Dimer Pharmaceuticals

Job title: CEO

Seminars:

Targeting Tumor Regulators in Pediatric High-Risk Neural Tumors (PHRNT), A Novel Small Molecule Approach to MYC-N Amplified Pediatric Cancers 4:40 pm

Novel small molecule therapy targeting tumor regulators in pediatric high-risk neural tumors (PHRNT), focusing on MYC-N amplified cancers. Cutting-edge approach that disrupts oncogenic pathways and restores protein homeostasis, offering a breakthrough treatment for pediatric cancers. Addressing a critical unmet need in pediatric oncology with the potential to reshape treatment paradigms and significantly improve survival ratesRead more

day: Day One Mid Day